. 2014 Jan 10;7(1):18–22. doi: 10.1159/000357801
Copyright © 2014 by S. Karger AG, Basel
This is an Open Access article licensed under the terms of the Creative Commons Attribution-NonCommercial 3.0 Unported license (CC BY-NC) (www.karger.com/OA-license), applicable to the online version of the article only. Users may download, print and share this work on the Internet for noncommercial purposes only, provided the original work is properly cited, and a link to the original work on http://www.karger.com and the terms of this license are included in any shared versions.
Fig. 1.
SBRT plan for treatment of recurrent disease in the transplanted liver.